Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Higgins

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
The American Journal of Gastroenterology|January 26, 2024
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter ExperienceJeffrey A Berinstein, Taylor Karl, Anish Patel, et al.
Inflammatory Bowel Diseases|July 13, 2022
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel DiseaseKimberly N Weaver, Xian Zhang, Xiangfeng Dai, et al.
The American Journal of Gastroenterology|November 4, 2010
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?Geert R D'Haens, Remo Panaccione, Peter D R Higgins, et al.
Gastroenterology|July 3, 2018
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative ColitisHans Herfarth, Edward L Barnes, John F Valentine, et al.
Inflammatory Bowel Diseases|October 16, 2024
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel DiseaseArthur J Kastl, Erica J Brenner, Kimberly N Weaver, et al.
Development (Cambridge, England)|October 24, 2022
Mapping the adult human esophagus in vivo and in vitroDaysha Ferrer-Torres, Joshua H Wu, Charles J Zhang, et al.
The New England Journal of Medicine|April 13, 2012
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitisB Joseph Elmunzer, James M Scheiman, Glen A Lehman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2024
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel DiseaseErica J Brenner, Kimberly N Weaver, Xian Zhang, et al.
The Lancet. Gastroenterology & Hepatology|November 30, 2019
Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trialEvan L Fogel, Glen A Lehman, Paul Tarnasky, et al.
The American Journal of Gastroenterology|September 17, 2022
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel DiseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
The American Journal of Gastroenterology|January 26, 2024
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter ExperienceJeffrey A Berinstein, Taylor Karl, Anish Patel, et al.
Inflammatory Bowel Diseases|July 13, 2022
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel DiseaseKimberly N Weaver, Xian Zhang, Xiangfeng Dai, et al.
The American Journal of Gastroenterology|November 4, 2010
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?Geert R D'Haens, Remo Panaccione, Peter D R Higgins, et al.
Gastroenterology|July 3, 2018
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative ColitisHans Herfarth, Edward L Barnes, John F Valentine, et al.
Inflammatory Bowel Diseases|October 16, 2024
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel DiseaseArthur J Kastl, Erica J Brenner, Kimberly N Weaver, et al.
Development (Cambridge, England)|October 24, 2022
Mapping the adult human esophagus in vivo and in vitroDaysha Ferrer-Torres, Joshua H Wu, Charles J Zhang, et al.
The New England Journal of Medicine|April 13, 2012
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitisB Joseph Elmunzer, James M Scheiman, Glen A Lehman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2024
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel DiseaseErica J Brenner, Kimberly N Weaver, Xian Zhang, et al.
The Lancet. Gastroenterology & Hepatology|November 30, 2019
Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trialEvan L Fogel, Glen A Lehman, Paul Tarnasky, et al.
The American Journal of Gastroenterology|September 17, 2022
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel DiseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
Pageof 29